Plunkett Research Online: AIM ImmunoTech Inc

AIM IMMUNOTECH INC (HEB) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

AIM ImmunoTech, Inc. is an immuno-pharmaceutical company focused on the research and development of therapeutics to treat multiple types of cancers, viruses and immune-deficiency disorders. The firm’s flagship products include the antiviral/immunotherapeutic drugs Ampligen and Alferon N Injection. .....


AIM IMMUNOTECH INC

Ticker: HEB
Exchange: ASE
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 352-448-7797
Fax:
Address: 2117 SW Highway 484
Ocala, FL 34473 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Thomas Equels CEO/Director/President/Vice Chairman of the Board
Adam Pascale CFO/Chief Accounting Officer
See More
AIM ImmunoTech, Inc. is an immuno-pharmaceutical company focused on the research and development of therapeutics to treat multiple types of cancers, viruses and immune-deficiency disorders. The firm’s flagship products include the antiviral/immunotherapeutic drugs Ampligen and Alferon N Injection. .....See More See More

$USD, In whole numbers 2019 2018 2017 2016 2015 2014 2013
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture